Dayan Wang
Impact in
- Infectious Diseases top 0.01%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- General Dentistry top 0.1%
Papers in
- Epidemiology 208
- Influenza Virus Research Studies 204
- Data-Driven Disease Surveillance 6
- Respiratory viral infections research 3
-
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 3
- Co-authors
- George Fu Gao (15 shared papers)Xingwang Li (2 shared papers)Weifeng Shi (7 shared papers)Xiang Zhao (25 shared papers)Xuejun Ma (5 shared papers)Guizhen Wu (7 shared papers)Wenjie Tan (5 shared papers)Wenbo Xu (4 shared papers)
- Journals
- China CDC Weekly (17 papers)Emerging Microbes & Infections (13 papers)Emerging infectious diseases (11 papers)Antiviral Research (10 papers)Scientific Reports (9 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dayan Wang
220 papers receiving 39.4k citations
Dayan Wang's Hit Papers
Peers
Comparison fields: 5 of 219
- Infectious Diseases 17.9k
- General Dentistry 416
- Modeling and Simulation 1.9k
- Epidemiology 9.9k
- Obstetrics and Gynecology 607
Countries citing papers authored by Dayan Wang
This map shows the geographic impact of Dayan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayan Wang more than expected).
Fields of papers citing papers by Dayan Wang
This network shows the impact of papers produced by Dayan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayan Wang. The network helps show where Dayan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dayan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Novel Coronavirus from Patients with Pneumonia in China, 2019 Hit paper breakdown → | 2020 | 20654 |
| 2 | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Hit paper breakdown → | 2020 | 8849 |
| 3 | Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus Hit paper breakdown → | 2013 | 2068 |
| 4 | Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Hit paper breakdown → | 2013 | 609 |
| 5 | Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study Hit paper breakdown → | 2014 | 553 |
| 6 | Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China Hit paper breakdown → | 2009 | 497 |
| 7 | Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses Hit paper breakdown → | 2013 | 496 |
| 8 | Global circulation patterns of seasonal influenza viruses vary with antigenic drift Hit paper breakdown → | 2015 | 416 |
| 9 | 2013 | 326 | |
| 10 | 2013 | 240 | |
| 11 | 2013 | 225 | |
| 12 | 2016 | 222 | |
| 13 | Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China | 2013 | 205 |
| 14 | Impact of COVID-19 outbreaks and interventions on influenza in China and the United States Hit paper breakdown → | 2021 | 195 |
| 15 | 2015 | 159 | |
| 16 | 2017 | 140 | |
| 17 | 2015 | 138 | |
| 18 | 2013 | 136 | |
| 19 | 2017 | 118 | |
| 20 | Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020 Hit paper breakdown → | 2022 | 117 |
About Dayan Wang
Dayan Wang is a scholar working on Epidemiology, Infectious Diseases, Modeling and Simulation, Genetics and Health, Toxicology and Mutagenesis, having authored 241 papers that have together received 40.8k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (204 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Data-Driven Disease Surveillance (6 papers), Respiratory viral infections research (3 papers), Genomics and Rare Diseases (3 papers), COVID-19 Clinical Research Studies (3 papers), Genetic Associations and Epidemiology (3 papers) and COVID-19 epidemiological studies (3 papers). The work is most often cited by research in Infectious Diseases (17.9k citations), General Dentistry (416 citations), Modeling and Simulation (1.9k citations), Epidemiology (9.9k citations) and Obstetrics and Gynecology (607 citations). Dayan Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include George Fu Gao, Xingwang Li, Weifeng Shi, Xiang Zhao, Xuejun Ma, Guizhen Wu, Wenjie Tan, Wenbo Xu, Baoying Huang and Peihua Niu. Their work appears in journals such as China CDC Weekly, Emerging Microbes & Infections, Emerging infectious diseases, Antiviral Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.